CHRNB4 anticorps

N° du produit ABIN1108430

L’anticorps anti-CHRNB4 Polyclonal Lapin est utilisé pour la détection de CHRNB4 dans des échantillons de Humain. Il a été validé pour WB, EIA et IHC (fro).

Aperçu rapide pour CHRNB4 anticorps (ABIN1108430)

Antigène: CHRNB4 (Cholinergic Receptor, Nicotinic, beta 4 (Neuronal) (CHRNB4))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CHRNB4 est non-conjugé

Application: Western Blotting (WB), Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Sections) (IHC (fro))

Détail du produit anti-CHRNB4 anticorps

Specificité: This antibody reacts with 56 kDa CHRNB4 protein.

Réactivité croisée (Details): Species reactivity (tested):Human.

Purification: Affinity Chromatography on Protein A

Immunogène: Synthetic peptide derived from CHRNB4 protein

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Reconstitution: Restore in distilled water.

Buffer: 0.1 M Tris, 0.1 M Glycine and 2 % Sucrose, None

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Prior to reconstitution store the antibody at -20 °C. Store reconstituted antibody at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détails sur CHRNB4

Antigène: CHRNB4 (Cholinergic Receptor, Nicotinic, beta 4 (Neuronal) (CHRNB4))

Autre désignation: Neuronal Acetylcholine Receptor Subunit beta-4

Sujet: The Nicotinic Acetylcholine Receptors (nAChRs) are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. The nAChRs are thought to be (hetero)pentamers composed of homologous subunits. After binding acetylcholine, the nAChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.Synonyms: CHRNB4, Nicotinic acetylcholine receptor subunit beta 4

ID gène: 1143

NCBI Accession: NP_000741